Irish Medtech Award Winners 2017
Friday, 8 December 2017
Bausch + Lomb were last night announced as the winners of Company of the Year 2017 at Medtech Rising: The Irish Medtech CEO Conference and Awards. Almost 500 senior medtech professionals attended the event hosted by the Ibec’s Irish Medtech Association, Enterprise Ireland, and IDA Ireland, 7 December, in the Radisson Blu Galway.
Speaking at the event, Acting Irish Medtech Association Director Eoghan Ó Faoláin said: “Medtech continues to be a high-performing sector in Ireland with 9 of the world’s top 10 medtech companies employing 38,000 people with major regional clusters in Galway, Waterford, Limerick, Cork, Sligo and Dublin. Bausch + Lomb have demonstrated great strategic vision with their expansion that doubled production levels while maintaining customer service and supporting innovation.
“It’s also great to be able to announce Tinderpoint as the winner of the inaugural Best European MedTech Week Campaign. This initiative is part of a major pan-European effort to help people better understand the value of medtech, and how it saves and improves lives”.
The winner of the Outstanding Contribution to Medtech Award 2017 went to Peter Walsh VP of Global Operations at Medtronic.
Bausch + Lomb Waterford site lead Mark Hennessy said: “This prestigious award is the culmination of what has been a truly remarkable year in the 37-year history of manufacturing here in Waterford. We completed a $200 million-plus investment project to support the production of our highly successful new daily disposable contact lens, Biotrue® ONEday, which was developed and brought to market from the Waterford site.
“As a result of this investment by our parent company, Valeant Pharmaceuticals International Inc., we have created an additional 300 jobs in Waterford. By installing the very latest contact lens manufacturing technologies we have now positioned Bausch + Lomb to meet our customer requirements in the rapidly growing daily disposable contact lens market”.
Enterprise Ireland Director Lifescience and Food Commercialisation and Manager, Lifesciences Sector Deirdre Glenn said: “Supporting innovative young companies with global ambition is a key focus of Enterprise Ireland and it’s great to see them succeed.
“Start-ups and SMEs make up 80 per cent of the Irish medtech sector and these are recognised in the Emerging Medtech Company Award which was won by Renew Health. This ambitious company has grown from four employees in 2014 to 50 today, and now has an international presence across Ireland, the UK, the Netherlands and Belgium. They already have two products on the market, including dental device Cerezen™, and they are expanding into the high-potential eHealth market - an area where Ireland is poised to become a global leader.
“Longboat Clinical, the winner of this year’s eHealth Innovation Award, helps bridge the gap between clinicians, experts and patients to promote integrated and compliant trials. As pioneers in the development of assisted protocols, Longboat’s innovative and transformational technologies provide site staff with the information they need, when they need it.”
IDA Ireland Head of Life Sciences, Engineering and Industrial Technology Division Michael Lohan said: “Ireland’s diverse and collaborative medtech cluster is one of the major selling points of doing business here. Winner of Partner/Supplier of the Year, Anecto, is testament to this ecosystem as they evolved from an initial focus as an electronics test house, employing eight people, to today's capabilities within a state of the art test facility serving multiple sectors including 80% of the world’s top 20 medtech companies.
“Ireland’s expertise is also significantly bolstered by our research capabilities. The NUI Galway based, SFI research centre CÚRAM is an exemplar with 250 research partners and affiliated partners collaborating with 27 industry partner across SMEs and FDI multinationals. These collaborations are creating future solutions to develop works class care in neurodegenerative diseases such as Parkinson and Alzheimer’s.”